Paragon Biosciences, founded by Jeff Aronin, is an innovative biopharmaceutical company, whose purpose is to develop FDA-approved, life-changing medicines. Paragon is an incubator of new companies and an invest in bioscience companies. Its goal is to develop drugs that will improve people’s lives.
Paragon is a people-centered company that concentrates on their needs to reduce and treat the negative impact of their diseases. The diseases are studied to understand the science that empowers the disease process. Thus, the focus is on the needs of individuals to discover treatments. The purpose of the companies, incubated by Paragon, under the direction by Jeff Aronin, is to find cures or treatments for the diseases based upon the underlying scientific investigation of the disease process.
The following biopharmaceutical work under Jeff Aronin and Paragon:
- Castle Creek Pharmaceuticals focuses on the development of therapies to treat dermatologic disorders.
- Harmony Biosciences is primarily responsible for obtaining FDA approval of the new drugs.
- Decade Pharmaceuticals is dedicated to developing Alzheimer’s disease treatment protocols.
- Precision BP is focused on the treatment of genetic oncology diseases.
Since Paragon’s products are regulated by the FDA, it has successfully positioned itself, with Jeff Aronin’s capable leadership, to develop medications for rare diseases that have no current medication available.
Jeff Aronin is the chairman & CEO of Paragon and is an entrepreneur, investor, innovator, and philanthropist (Thenewsversion). Aronin was granted an M.B.A. and received a B.S. from Northwestern Illinois University. He is on the adjunct faculty, teaching entrepreneur classes at the University of Chicago and was enrolled at the Kellogg School of Management as a postgraduate student. He was recognized as a Henry Crown Fellow at the Aspen Institute.
Jeff Aronin became interested in pharmaceuticals by following a physician who was treating an epileptic pediatric patient. Instead of giving the patient brain surgery, the typical medical treatment for that disease, the doctor gave the patient a medical drug. This drug therapy was successful in decreasing the patient’s epileptic seizures. It was this dramatic experience that influenced Aronin to pursue a career in pharmaceuticals.